Skip to main content
Clinical Trials/CTRI/2024/05/066638
CTRI/2024/05/066638
Not yet recruiting
Phase 2

Assessment of pre and post therapeutic outcome of reproductive age group women suffering from bacterial vaginosis by individualized homoeopathic medicine comparing its effect through in- vitro analysis - NI

ational Institute of Homoeopathy0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Institute of Homoeopathy
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
ational Institute of Homoeopathy

Eligibility Criteria

Inclusion Criteria

  • Patients suffering from symptoms of vaginal white discharge.
  • Patient who’s satisfying the Amsel’s criteria.
  • Patient age group 15\-49 years of female, of any religion, of any socio\-economic background.
  • Patents who know and understand either Hindi or English or Bengali.
  • Patients who are willing to give assent and/or consent.
  • Patients who are willing to give consent for clinical examination and sample collection.

Exclusion Criteria

  • Patients suffering from other infectious disease like trichomoniasis, candidiasis.
  • Patient who’s taking OCPs, who’s Pregnant and lactating.
  • Patient who are already taking homoeopathic treatment for any other chronic disease.
  • Patient suffering from any life threatening/ Psychiatric/ systemic illness or Immunocompromised state or other significant disease conditions.
  • Substance abuse and/or dependence.
  • History of antibacterial therapy within two weeks prior to their attendance.
  • Women with genital malignancy excluded from the study

Outcomes

Primary Outcomes

Not specified

Similar Trials